Results 1 to 10 of about 170,643 (213)
Amikacin: Uses, Resistance, and Prospects for Inhibition
Molecules, 2017 Aminoglycosides are a group of antibiotics used since the 1940s to primarily treat a broad spectrum of bacterial infections. The primary resistance mechanism against these antibiotics is enzymatic modification by aminoglycoside-modifying enzymes that are
Maria Soledad Ramirez +1 more
exaly +4 more sources
Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
Frontiers in Microbiology, 2021 Heteroresistance can lead to treatment failure and is difficult to detect by the methods currently employed by clinical laboratories. The aim of this study was to investigate the prevalence of the amikacin-heteroresistant Klebsiella pneumoniae strains ...
Feiyang Zhang +7 more
doaj +2 more sources
Isolation and Antimicrobial Susceptibility of Nontuberculous Mycobacteria in a Tertiary Hospital in Korea, 2016 to 2020 [PDF]
Tuberculosis and Respiratory Diseases, 2023 Background There is a global increase in isolation of nontuberculous mycobacteria (NTM). The aim of the study was to analyze longitudinal trends of NTM identification and pattern of antimicrobial susceptibility testing.
Keun Ju Kim +3 more
doaj +1 more source
Tikrit Journal of Pure Science, 2023 The current investigation aimed to evaluate the role of Punica granatum juice extract to reduce nephrotoxic formation by amikacin in male and female albino rabbits by measuring some criteria for biochemical functions, such as creatinine, urea, albumin ...
Hazim I. Ahmad, Sabe Kh. Al-Tai
doaj +1 more source
Comparative Study between Combined Intravenous and Nebulized Amikacin versus Intravenous Amikacin Alone for Treatment of Ventilator Associated Pneumonia [PDF]
International Journal of Medical Arts, 2022 Background: Ventilator-associated pneumonia [VAP] is a type of infection affecting the lower part of the respiratory system related to the intubation of trachea.Patients and methods: An observational randomized prospective study approved by the ethical ...
Sameh Seyam +3 more
doaj +1 more source
Microbiology Spectrum, 2022 The emergence of Mycobacterium abscessus complex (MABC) infection is the most noteworthy health care problem. Clarithromycin (CLA) and amikacin (AMK) constitute the cornerstone of treatment for patients infected with MABC; thus, early detection of ...
Haoran Li +8 more
doaj +1 more source
Microbiology Spectrum, 2023 In view of the current increase and spread of antimicrobial resistance (AMR), there is an urgent need to find new strategies to combat it. This study had two aims.
Marta Palau +9 more
doaj +1 more source
Single-dose amikacin plus 7 days of amoxicillin/clavulanate to treat acute cystitis caused by extended-spectrum beta-lactamase-producing Escherichia coli: A retrospective cohort study [PDF]
Investigative and Clinical Urology, 2021 Purpose: Treatment options for urinary tract infection (UTI) caused by extended-spectrum beta-lactamase (ESBL)-producing organisms are limited other than carbapenem. Accordingly, clinicians should investigate alternative antimicrobial options for limited
Sun Tae Ahn +6 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2020 Urinary tract infections (UTI) are common infections that can be mild to life threatening. However, increased bacterial resistance and poor patient compliance rates have limited the effectiveness of conventional antibiotic therapies.
Zi-Xing Zhong +25 more
doaj +1 more source
Frontiers in Veterinary Science, 2021 Septic arthritis causes significant morbidity and mortality in veterinary and human clinical practice and is increasingly complicated by multidrug-resistant infections.
Lynn Pezzanite +12 more
doaj +1 more source